CD4+CD45RA+ T-cells from early diffuse systemic sclerosis patients produce high levels of interleukin-17
- PDF / 83,617 Bytes
- 1 Pages / 595.28 x 793.7 pts Page_size
- 28 Downloads / 164 Views
POSTER PRESENTATION
Open Access
CD4+CD45RA+ T-cells from early diffuse systemic sclerosis patients produce high levels of interleukin-17 Lenny van Bon1*, Marta Cossu1, Wim van den Berg1, Madelon Vonk1, Hans Koenen2, Timothy Radstake1 From 6th European Workshop on Immune-Mediated Inflammatory Diseases Nice, France. 23-25 November 2011 Background In Systemic Sclerosis (SSc) the detrimental role of the immune system is a topic of great interest. In recent genetic association studies most genes identified to date are immunity related genes. A contribution of T-cells as important cytokine producing cells is shown and the skewing of this population can be an important player in the maintenance and progression of inflammation and fibrosis. Material and methods After inclusion 20 SSc patients were stratified as having diffuse or limited disease according to the extent of skin involvement. Patients were further stratified as having early or late disease, early being less then 2 years after the start of the first non-Raynaud symptom. After isolation from 60 ml of venous blood CD4+ T-cells were divided in CD45RO and CD45RA by MACS bead isolation. Cells were stimulated with PMA and iomycin. Cytokine levels were measured in supernatant using the Luminex Bead Array. Results The IL-17 production was clearly increased in the supernatant of CD4+CD45RO cells but even more clearly in the CD4+CD45RA cells from early diffuse SSc patients compared to healthy controls or limited SSc patients. Limited SSc patients showed a clear decrease in IL-10 and interferon-g production.
inflammatory phenotype in this T-cell subset. Together with a normal production of IL-13 this could create a proinflmmatory and profibrotic condition in this subset of patients. The decreased production of IL-10 and interferon-g in limited SSc patients shows a decrease of Th1 and Treg involvement in this disease subset. A prospective study must show if these findings could contribute to the assessing the prognosis and the treatment of SSc patients. Author details 1 Dept. of Rheumatology, Radboud University Nijmegen Medical Centre, The Netherlands. 2Dept. of Blood Transfusion and Transplantation Immunology, Radboud University Nijmegen Medical Centre, The Netherlands. Published: 23 November 2011
doi:10.1186/1479-5876-9-S2-P62 Cite this article as: van Bon et al.: CD4+CD45RA+ T-cells from early diffuse systemic sclerosis patients produce high levels of interleukin-17. Journal of Translational Medicine 2011 9(Suppl 2):P62.
Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color figure charges
Conclusions The CD4+CD45RA+ T-cells from early diffuse SSc patients produce increased levels of IL-17 suggestion a more pro1 Dept. of Rheumatology, Radboud University Nijmegen Medical Centre, The Netherlands Full list of author information is available at the end of the article
• Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Resea
Data Loading...
